Decision to cut disability allowance payments disappointing
Government's decision to cut disability allowance payments disappointing
Life can be expensive for a family with a sick child. The 8-year-old Manurewa boy whose asthma is so bad that he missed one in every four school days last year evidenced this situation. Every month there is Ventolin at $18 a month, Serevent, at $5 a month and in winter the costs increase including possible steroid medication Redipred, at $10 a month, and a daily tablet, Singulair, costing $96 a month. Doctor's visits cost another $10 a visit about three times a month in winter.
"It distresses us to hear about parents who aren’t giving their children the required medication because they can’t afford it," said Dr Tristram Ingham, Maori strategic advisor for the Asthma Foundation.
The government’s decision to cut disability allowance payments will have long term potential impacts on families caring for a child with a long term condition such as asthma - through health care access (affordability of prescriptions/ doctors visits etc), household income (through lost earnings whilst caring for child) hence nutrition, housing quality etc.
With 1 in 7 children taking asthma medication in New Zealand it is imperative that parents and carers can financially afford their continued care.
A soon to be released report detailing respiratory health statistics notes that prevalence of asthma is higher for the most deprived for both adults and children with the most socioeconomically deprived also having a hospitalisation rate more than three times that of the wealthiest areas.
While we welcome the government's initiative of providing free doctors visits for all children under 13 from July, removing this subsidy so that parents struggle to keep their children well will only result in more of our tamariki in hospital and higher health costs for New Zealand.
Notes for editors
In New Zealand
• Over 500,000 New
Zealanders have asthma
• One in seven children
(107,000) and one in nine adults (389,000) have
asthma
• In 2013 asthma was responsible for 7,400
hospitalisations
• People still die from asthma, with
69 deaths in 2011
• In the five years between 2006 and
2011:
o Asthma deaths were six times higher for Pacific
Peoples and five times higher for Maori compared to NZ
European
o People in the most deprived areas were three
times more likely to die of asthma than people in the least
deprived areas
o Children living in the most deprived
areas were more likely to have asthma (15%) than children
living in the least deprived areas (10%)
• Maori have a
higher prevalence of asthma compared to non-Maori children,
tend to have more severe symptoms, require hospitalisation
for asthma almost three times as often, and require more
time off school because of asthma
• $800,000,000 is the
conservative estimate of the annual economic burden of
asthma
• Asthma affects approximately 235 million
people worldwide and the prevalence is rising
• Asthma
causes an estimated 250,000 deaths worldwide
annually
About the Asthma
Foundation
The Asthma Foundation is New Zealand’s
sector authority on asthma and other respiratory illnesses.
We advocate to government and raise awareness of respiratory
illnesses, fund research for better treatments and educate
on best practice. We provide resources on our website and
support our affiliated asthma societies and trusts in
providing education, support and advice. For more
information, visit the Asthma Foundation’s website http://www.asthmafoundation.org.nz/.
ENDS